Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Location: Switzerland, Basel-Landschaft, Allschwil
Employees: 1-10
Total raised: $69.76M
Founded date: 2019
Investors 5
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
| - | Ysios Capi... | ysioscapit... |
| - | VentureLab | venturelab... |
| 13.11.2020 | Kurma Part... | kurmapartn... |
| - | High-Tech ... | htgf.de |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 21.04.2021 | Series A | $26.14M | - |
| 12.11.2020 | Series A | $21.77M | - |
| 12.11.2020 | Series A | $21.86M | - |
Mentions in press and media 20
| Date | Title | Description | Source |
| 22.01.2024 | Synendos Therapeutics’ drug against CNS disorders cleared fo... | Synendos, a biopharmaceutical company from Basel, develops a new class of small molecules, so call... | startuptic... |
| 05.06.2023 | A significant number of Swiss biotechs exhibit in Boston | The BIO International Convention awaits more than 14,000 biotechnology and pharma leaders in Bosto... | startuptic... |
| 23.05.2022 | Swiss Biotechs display their innovations at BIO 2022 Interna... | After a successful online event last year – with over 6,000 participants from at least 55 countrie... | startuptic... |
| 21.04.2021 | Synendos Therapeutics expands Series A to CHF 24 million wit... | Synendos Therapeutics expands Series A to CHF 24 million with new investment 21.04.2021 08:32, Isabe... | venturelab... |
| 21.04.2021 | Synendos Therapeutics expands Series A to CHF 24 million wit... | Synendos is developing first-in-class inhibitors that modulate a newly identified drug target in the... | venturekic... |
| 20.04.2021 | Ysios Capital invierte en Synendos Therapeutics | 20/04/2021 Nota de prensa YSIOS CAPITAL INVIERTE EN SYNENDOS THERAPEUTICS. − Synendos (Basel Suiz... | webcapital... |
| 20.04.2021 | Ysios Capital invests in Synendos Therapeutics | 20/04/2021 Press release SYNENDOS THERAPEUTICS EXPANDIS SERIES A TO CHF 24 MILLION WITH NEW INVEST... | webcapital... |
| 20.04.2021 | Synendos Therapeutics raises additional funds in Series A | Synendos is a biopharmaceutical company developing a new class of small molecules aimed at restori... | startuptic... |
| 20.04.2021 | Synendos Therapeutics raises additional funds in Series A | Synendos is a biopharmaceutical company developing a new class of small molecules aimed at restoring... | startuptic... |
| 12.11.2020 | Synendos Therapeutics secures CHF 20 million | Incorporated in April 2019 as a spinoff of the University of Bern and the research consortium, NCCR ... | startuptic... |
Show more